Novo Nordisk's stock has dropped over 20%, but its core business remains strong and diversified, making this an attracti

Must Reads

FREE ARTICLE

Novo Nordisk: Catch That Falling Knife 

Novo Nordisk's stock has dropped over 20%, but its core business remains strong and diversified, making this an attractive entry point for investors. ...

Read for Free

FREE ARTICLE

Novo Nordisk: Catch That Falling Knife 

Novo Nordisk's stock has dropped over 20%, but its core business remains strong and diversified, making this an attractive entry point for investors. ...

Read for Free
 

FEATURED:

Watch the Replay: Investing for Income in an Uncertain Market

In his recent webinar, author and investor Steven Bavaria demonstrated how investors can build a resilient portfolio using high-yield credit investments such as closed-end funds, BDCs, and CLOs. Watch the replay now.

Watch the Replay
Watch Steven Bavaria's webinar: Investing for Income in an Uncertain Market

Any views or opinions expressed in the webinar do not reflect those of Seeking Alpha as a whole.

 

Ignore The Fed-Trump Drama, Invest With 10% Yields

Political drama between Trump and Powell over interest rates is entertaining, but I avoid letting it influence my investment decisions. The Income Met...

Continue Reading
 

Novo Nordisk: Is This An Overreaction Or The End Of The GLP-1 Fairy Tale?

The sharp Novo Nordisk A/S stock drop reflects real concerns: slowing demand, CEO transition, rising competition, and macro headwinds. GLP-1 hype is f...

Continue Reading
 

2025 AI Tech Rally Vs. 1999 Dotcom Bubble: You Ain't Seen Nothing Yet

Today's tech rally is driven by highly profitable, dominant giants, making this cycle fundamentally stronger than the dotcom bubble, despite record co...

Continue Reading
 

AMD Just Flipped The Script On AI: A 70% Price Hike That Could Change Everything

AMD’s rumored 7